<ul>
<li>Prologis 股票大涨：为何这一涨势可能会持续</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，Prologis、Canopy Growth 和 Ascendis Pharma A/S 是今天值得关注的三只成长股。成长股是指那些预期收益、收入或现金流将以高于市场平均水平的速度增长的公司的股票，投资者主要是为了资本增值而非当前收入而购买这些股票。这些公司通常将利润再投资于扩张，交易时的估值倍数较高（例如市盈率），并且可能更具波动性，因此投资者愿意接受更大的短期风险，以期获得更高的长期回报。这些公司在过去几天内的交易量是所有成长股中最高的。</p>
<h2>Prologis (PLD)</h2>
<p>Prologis, Inc.是全球物流房地产的领导者，专注于高壁垒、高增长市场。截至 2024 年 3 月 31 日，该公司在 19 个国家拥有或投资于的物业和开发项目预计总面积约为 12 亿平方英尺（1.15 亿平方米）。</p>
<ul>
<li>3 只在市场波动中应持有的股息股票</li>
</ul>
<p>阅读我们关于 PLD 的最新研究报告</p>
<h2>Canopy Growth (CGC)</h2>
<p>Canopy Growth Corporation 及其子公司从事大麻和基于工业大麻的产品的生产、分销和销售，主要用于娱乐和医疗目的，业务遍及美国、加拿大、德国及国际市场。它通过加拿大大麻、国际市场大麻和 Storz &amp; Bickel 三个部门运营。</p>
<ul>
<li>3 只推动 AI 基础设施繁荣的云计算股票</li>
</ul>
<p>阅读我们关于 CGC 的最新研究报告</p>
<h2>Ascendis Pharma A/S (ASND)</h2>
<p>Ascendis Pharma A/S 是一家生物制药公司，专注于开发满足未满足医疗需求的疗法。它提供 SKYTROFA 用于治疗生长激素缺乏症（GHD）患者。该公司还在临床开发中开发三种独立的内分泌罕见疾病产品候选药物，并专注于推进肿瘤治疗候选药物。</p>
<p>阅读我们关于 ASND 的最新研究报告</p>
<h2>推荐故事</h2>
<ul>
<li>MarketBeat 在 2025 年 12 月的五大必持股票</li>
<li>这两只股票如何赢得 2025 年的 AI 竞赛——2026 年又将如何</li>
<li>英特尔以低价收购 AI 技术</li>
<li>3 只量子股票在下一次计算革命中值得关注</li>
<li>工业领域大幅突破：现在必须关注的 3 只股票</li>
<li>3 只科技股下跌超过 60%——哪一只值得购买？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Prologis 吗？</h2>
<p>在考虑 Prologis 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Prologis 并不在名单上。</p>
<p>虽然 Prologis 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Ascendis制药

安博

<p>Prologis、Canopy Growth 和 Ascendis Pharma A/S 被 MarketBeat 的股票筛选工具列为值得关注的顶级成长股。这些公司预计在盈利、收入或现金流方面将实现高于平均水平的增长。Prologis 在物流房地产领域处于领先地位，Canopy Growth 专注于大麻产品，而 Ascendis Pharma 则开发满足未满足医疗需求的疗法。尽管短期存在风险，投资者仍被建议考虑这些股票以获取潜在的长期回报</p>

<ul>
<li>Prologis Stock Surges: Why the Rally May Continue</li>
</ul>
<div class="lb-trans"><ul>
<li>Prologis 股票大涨：为何这一涨势可能会持续</li>
</ul>
</div><p>Prologis, Canopy Growth, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose earnings, revenue, or cash flow are expected to grow at an above‑average rate compared with the broader market, and are bought by investors mainly for capital appreciation rather than current income. These companies often reinvest profits into expansion, trade at higher valuation multiples (e.g., P/E ratios), and can be more volatile, so investors accept greater short‑term risk for the prospect of higher long‑term returns. These companies had the highest dollar trading volume of any Growth stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，Prologis、Canopy Growth 和 Ascendis Pharma A/S 是今天值得关注的三只成长股。成长股是指那些预期收益、收入或现金流将以高于市场平均水平的速度增长的公司的股票，投资者主要是为了资本增值而非当前收入而购买这些股票。这些公司通常将利润再投资于扩张，交易时的估值倍数较高（例如市盈率），并且可能更具波动性，因此投资者愿意接受更大的短期风险，以期获得更高的长期回报。这些公司在过去几天内的交易量是所有成长股中最高的。</p>
</div><h2>Prologis (PLD)</h2>
<div class="lb-trans"><h2>Prologis (PLD)</h2>
</div><p>Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.</p>
<div class="lb-trans"><p>Prologis, Inc.是全球物流房地产的领导者，专注于高壁垒、高增长市场。截至 2024 年 3 月 31 日，该公司在 19 个国家拥有或投资于的物业和开发项目预计总面积约为 12 亿平方英尺（1.15 亿平方米）。</p>
</div><ul>
<li>3 Dividend Stocks to Hold Through Market Volatility This Fall</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在市场波动中应持有的股息股票</li>
</ul>
</div><p>Read Our Latest Research Report on PLD</p>
<div class="lb-trans"><p>阅读我们关于 PLD 的最新研究报告</p>
</div><h2>Canopy Growth (CGC)</h2>
<div class="lb-trans"><h2>Canopy Growth (CGC)</h2>
</div><p>Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz &amp; Bickel segments.</p>
<div class="lb-trans"><p>Canopy Growth Corporation 及其子公司从事大麻和基于工业大麻的产品的生产、分销和销售，主要用于娱乐和医疗目的，业务遍及美国、加拿大、德国及国际市场。它通过加拿大大麻、国际市场大麻和 Storz &amp; Bickel 三个部门运营。</p>
</div><ul>
<li>3 Cloud Build-Out Stocks Behind the AI Infrastructure Boom</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只推动 AI 基础设施繁荣的云计算股票</li>
</ul>
</div><p>Read Our Latest Research Report on CGC</p>
<div class="lb-trans"><p>阅读我们关于 CGC 的最新研究报告</p>
</div><h2>Ascendis Pharma A/S (ASND)</h2>
<div class="lb-trans"><h2>Ascendis Pharma A/S (ASND)</h2>
</div><p>Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.</p>
<div class="lb-trans"><p>Ascendis Pharma A/S 是一家生物制药公司，专注于开发满足未满足医疗需求的疗法。它提供 SKYTROFA 用于治疗生长激素缺乏症（GHD）患者。该公司还在临床开发中开发三种独立的内分泌罕见疾病产品候选药物，并专注于推进肿瘤治疗候选药物。</p>
</div><p>Read Our Latest Research Report on ASND</p>
<div class="lb-trans"><p>阅读我们关于 ASND 的最新研究报告</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in December 2025</li>
<li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li>
<li>Intel Snaps Up AI Tech for Pennies on the Dollar</li>
<li>4 Quantum Stocks to Watch as the Next Computing Revolution Unfolds</li>
<li>Massive Breakout in Industrials: 3 Must-Watch Stocks Now</li>
<li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 在 2025 年 12 月的五大必持股票</li>
<li>这两只股票如何赢得 2025 年的 AI 竞赛——2026 年又将如何</li>
<li>英特尔以低价收购 AI 技术</li>
<li>3 只量子股票在下一次计算革命中值得关注</li>
<li>工业领域大幅突破：现在必须关注的 3 只股票</li>
<li>3 只科技股下跌超过 60%——哪一只值得购买？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Prologis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Prologis 吗？</h2>
</div><p>Before you consider Prologis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Prologis 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Prologis 并不在名单上。</p>
</div><p>While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Prologis 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

12 月 17 日值得添加到您的观察名单中的顶级成长股